Clarivate CLVT
$2.01 −$0.04 (-1.95%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $1.97 -1.80%
Open$1.99
Prev close$2.05
Day range$1.99 – $2.12
Volume5.70M
Market cap$1.29B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$481.60M-9.2% YoY
Operating profit$44.80M+13.7% YoY
Net profit-$80.80M-185.5% YoY
Diluted EPS-$0.13-225.0% YoY
Free cash flow$110.20M-4.6% YoY
Operating cash flow$165.60M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin67.9%
Operating margin7.6%
Net margin-16.2%
Return on equity-8.2%
Return on assets-3.6%
Return on invested capital-2.2%
Current ratio0.88
Liabilities / assets56.5%
Cash & investments$257.00M
Total debt$4.17B
Net cash (debt)-$3.91B
Free cash flow / sales13.5%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $481.60M | $587.30M | $585.50M | $2.46B | $908.50M |
| Total Operating Revenue | $481.60M | $587.30M | $585.50M | $2.46B | $908.50M |
| Cost of Revenue | $139.00M | $185.50M | $192.10M | $833.60M | $322.30M |
| Gross Profit | $342.60M | $401.80M | $393.40M | $1.62B | $586.20M |
| Operating Expense | $297.80M | $365.80M | $363.80M | $1.45B | $499.40M |
| Selling and Admin Expenses | $134.60M | $181.60M | $176.30M | $708.60M | $255.40M |
| Depreciation & Amortization & Depletion | $162.30M | $185.70M | $184.00M | $757.20M | $258.00M |
| -Depreciation & Amortization | $162.30M | $185.70M | $184.00M | $757.20M | $258.00M |
| Other Operating Expenses | $900,000.00 | -$1.50M | $3.50M | -$16.30M | -$14.00M |
| Operating Profit | $44.80M | $36.00M | $29.60M | $172.10M | $86.80M |
| Net Non-Operating Interest Income (Expense) | -$61.00M | -$60.40M | -$59.00M | -$265.40M | -$66.00M |
| Non-Operating Interest Expense | $61.00M | $60.40M | $59.00M | $265.40M | $66.00M |
| Other Income (Expense) | -$4.70M | -$236.20M | $600,000.00 | -$100.60M | -$30.40M |
| Gain on Sale of Security | -$200,000.00 | -$2.40M | $12.60M | -$34.90M | $1.00M |
| Special Income (Charges) | -$4.50M | -$233.80M | -$12.00M | -$65.70M | -$31.40M |
| -Less:Restructuring and Mergern & Acquisition | $4.50M | $12.10M | $12.00M | $50.70M | $16.40M |
| Pretax Profit | -$20.90M | -$260.60M | -$28.80M | -$193.90M | -$9.60M |
| Tax | $5.50M | $8.00M | $11.40M | $7.20M | -$21.80M |
| Net Profit | -$80.80M | -$268.60M | -$40.20M | -$201.10M | $3.10M |
| Profit from Continuing Operations | -$26.40M | -$268.60M | -$40.20M | -$201.10M | $12.20M |
| Net Income from Discontinuous Operations | -$54.40M | – | – | – | – |
| Net Income to Parent Company | -$80.80M | -$268.60M | -$40.20M | -$201.10M | $3.10M |
| Net Income to Common Stockholders | -$80.80M | -$268.60M | -$40.20M | -$201.10M | $3.10M |
| Basic EPS | -$0.13 | -$0.42 | -$0.06 | -$0.30 | $0.00 |
| Diluted EPS | -$0.13 | -$0.42 | -$0.06 | -$0.30 | $0.00 |
| -Less:Impairment of Capital Assets | – | $221.70M | – | $15.00M | $15.00M |
| -Gain on Sale Of Business | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $10.37B | $10.49B | $10.93B | $11.07B | $11.07B |
| Total Current Assets | $1.23B | $1.21B | $1.30B | $1.31B | $1.31B |
| Cash and Cash Equivalents & Short-Term Investments | $257.00M | $217.70M | $232.30M | $329.20M | $329.20M |
| -Cash and Cash Equivalents | $257.00M | $217.70M | $232.30M | $329.20M | $329.20M |
| Receivables | $747.40M | $827.90M | $882.90M | $821.70M | $821.70M |
| -Accounts Receivable | $747.40M | $827.90M | $882.90M | $821.70M | $821.70M |
| Prepaid Assets | $95.70M | $107.10M | $109.10M | $94.20M | $94.20M |
| Other Current Assets | $61.60M | $61.50M | $66.90M | $64.90M | $64.90M |
| Total Non-Current Assets | $9.14B | $9.27B | $9.63B | $9.76B | $9.76B |
| Net PPE | $83.30M | $88.30M | $93.40M | $99.30M | $99.30M |
| -Gross PPE | $83.30M | $88.30M | $93.40M | $199.70M | $199.70M |
| Goodwill and Other Intangible Assets | $8.24B | $9.08B | $9.43B | $9.57B | $9.57B |
| -Goodwill | $1.09B | $1.34B | $1.57B | $1.57B | $1.57B |
| -Other Intangible Assets | $7.16B | $7.73B | $7.86B | $8.01B | $8.01B |
| Non-Current Deferred Assets | $19.40M | $17.90M | $16.50M | $17.20M | $17.20M |
| Other Non-Current Assets | $789.00M | $86.50M | $85.80M | $68.10M | $68.10M |
| Total Liabilities | $5.85B | $5.95B | $6.14B | $6.23B | $6.23B |
| Total Current Liabilities | $1.40B | $1.44B | $1.54B | $1.57B | $1.57B |
| Payables | $117.20M | $152.90M | $135.70M | $150.60M | $150.60M |
| -Accounts Payable | $117.20M | $152.90M | $135.70M | $150.60M | $150.60M |
| Current Accrued Expenses | $276.30M | $268.50M | $286.30M | $210.20M | $210.20M |
| Short-Term Debt and Capital Lease Obligation | $17.90M | $18.30M | $19.10M | $119.90M | $119.90M |
| -Current Debt | $1.60M | $1.60M | $1.50M | $101.50M | $101.50M |
| -Current Capital Lease Obligation | $16.30M | $16.70M | $17.60M | $18.40M | $18.40M |
| Current Deferred Liabilities | $761.30M | $897.00M | $1.00B | $941.40M | $941.40M |
| Other Current Liabilities | $144.50M | – | – | – | – |
| Total Non-Current Liabilities | $4.45B | $4.51B | $4.60B | $4.66B | $4.66B |
| Long Term Debt and Capital Lease Obligation | $4.17B | $4.24B | $4.32B | $4.36B | $4.36B |
| -Long Term Debt | $4.14B | $4.21B | $4.28B | $4.32B | $4.32B |
| -Long Term Capital Lease Obligation | $29.20M | $29.90M | $33.70M | $37.90M | $37.90M |
| Non-Current Deferred Liabilities | $195.00M | $197.90M | $205.00M | $212.10M | $212.10M |
| Other Non-Current Liabilities | $72.60M | $75.80M | $75.90M | $86.20M | $86.20M |
| Total Equity | $4.51B | $4.54B | $4.79B | $4.84B | $4.84B |
| Stockholders' Equity | $4.51B | $4.54B | $4.79B | $4.84B | $4.84B |
| Capital Stock | $12.83B | $12.82B | $12.80B | $12.81B | $12.81B |
| -Common Stock | $12.83B | $12.82B | $12.80B | $12.81B | $12.81B |
| Retained Earnings | -$7.90B | -$7.82B | -$7.55B | -$7.51B | -$7.51B |
| Gains/Losses Not Affecting Retained Earnings | -$407.20M | -$454.30M | -$457.70M | -$453.10M | -$453.10M |
| Restricted Cash | – | – | $9.90M | – | – |
| -Accumulated Depreciation | – | – | – | -$100.40M | -$100.40M |
| -Preferred Stock | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $165.60M | $98.70M | $134.70M | $628.50M | $159.90M |
| Net cash flow from continuing operations | $165.60M | $98.70M | $134.70M | $628.50M | $159.90M |
| Net Income from Continuing Operations | -$80.80M | -$268.60M | -$40.20M | -$201.10M | $3.10M |
| Depreciation & Depletion & Amortization | $162.30M | $185.70M | $184.00M | $757.20M | $189.10M |
| Deferred Tax | $1.50M | – | – | -$41.50M | -$29.90M |
| Other Non-Cash Items | $10.90M | $6.10M | -$13.50M | $47.30M | $6.10M |
| Change in Working Capital | -$1.30M | -$50.10M | -$9.80M | $3.50M | -$26.20M |
| -Change in Receivables | $30.60M | $51.00M | -$62.30M | -$5.00M | -$11.20M |
| -Change in Prepaid Assets | -$1.60M | $1.90M | -$15.20M | -$7.50M | -$300,000.00 |
| -Change in Payables and Accrued Expense | $3.60M | -$1.80M | -$49.30M | $11.50M | -$27.50M |
| -Change in Other Current Assets | -$2.00M | $3.70M | -$8.70M | $3.20M | $2.70M |
| -Change in Other Current Liabilities | -$100,000.00 | $0.00 | -$3.60M | $9.30M | $9.80M |
| -Change In Other Working Capital | -$31.80M | -$104.90M | $129.30M | -$8.00M | $300,000.00 |
| Net cash flow from investing | -$55.40M | -$54.70M | -$55.80M | -$263.20M | -$70.70M |
| Net Cash Flow from Continuing Investing Activities | -$55.40M | -$54.70M | -$55.80M | -$263.20M | -$70.70M |
| Capital Expenditure | -$55.40M | -$54.70M | -$55.80M | -$263.20M | -$70.70M |
| Financing Cash Flow | -$73.80M | -$68.90M | -$162.30M | -$343.10M | -$77.90M |
| Net Cash Flow from Continuing Financing Activities | -$73.80M | -$68.90M | -$162.30M | -$343.10M | -$77.90M |
| Net Issuance Payments Of Debt | -$73.10M | -$72.60M | -$138.50M | -$100.00M | $0.00 |
| Net Common Stock Issuance | $0.00 | $0.00 | -$18.10M | -$224.50M | -$75.00M |
| Net Other Financing Charges | -$700,000.00 | $3.70M | -$5.70M | -$18.60M | -$2.90M |
| Ending Cash Balance | $257.00M | $217.70M | $242.20M | $329.20M | $329.20M |
| Net Change in Cash | $36.40M | -$24.90M | -$83.40M | $22.20M | $11.30M |
| Beginning Cash Balance | $217.70M | $242.20M | $329.20M | $295.20M | $318.70M |
| Effect of Exchange Rate Changes | $2.90M | $400,000.00 | -$3.60M | $11.80M | -$800,000.00 |
| Free Cash Flow | $110.20M | $44.00M | $78.90M | $365.30M | $89.20M |
| Net Business Purchase and Sale | – | – | – | $0.00 | $0.00 |
| Cash Dividends Paid | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on CLVT.
Sign in to join the discussion.